NASDAQ · EVO
Evotec SE financials
$1.64+3.14%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '25 Dec 31 | Q4 '24 Dec 31 | Q4 '23 Dec 31 | Q4 '22 Dec 31 | Q4 '21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Gross margin | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | — | — | — | — | — |
| Net margin | — | — | — | — | — |
| Diluted EPS | — | — | — | — | — |
| EBITDA | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating cash flow | — | — | — | — | — |
| Free cash flow | — | — | — | — | — |
| Diluted shares | 177.6M | 177.3M | 176.9M | 176.7M | 166.4M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $491.0M | $318.8M | $564.8M | $445.3M | $790.3M |
| Short-term investments | $67.9M | $94.1M | $117.1M | $337.7M | $179.9M |
| Total debt | $403.6M | $408.7M | $692.2M | $551.1M | $409.6M |
| Total assets | $2.01B | $1.99B | $2.49B | $2.42B | $2.53B |
| Total liabilities | $1.06B | $998.9M | $1.25B | $1.15B | $969.0M |
| Shareholders' equity | $954.7M | $991.2M | $1.24B | $1.27B | $1.56B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology